| Inverness Medical Innovations Announces First Quarter 2010 Results (PR Newswire) Inverness Medical Innovations, Inc. , a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced its financial results for the quarter ended March 31, 2010. us.rd.yahoo.com |
Geron Corporation Q1 2010 Earnings Call Transcript Geron Corporation (GERN)Q1 2010 Earnings CallApril 30, 2010 11:00 a.m. ESTComplete Story » seekingalpha.com |
Medicaid Stalemate Tests States A number of states are preparing to make deep cuts to Medicaid as a federal stalemate over funding for the poor drags on—even as they face mandates to expand the program under the new health-care law. online.wsj.com |
Orexigen Signs Obesity-Drug Pact With Takeda Orexigen signed a North American partnership for its experimental obesity drug Contrave with Takeda Pharmaceutical. online.wsj.com |
Avanir: Insider Selling and Shelf Registration Are No Big Deal Rockford Coscia submits: After my post earlier this week on AVP-923, a potential new treatment from Avanir Pharmaceutials (AVNR) for psuedobulbar affect (PBA), I wanted to take the opportunity to dive right into the two red flags I alluded to: the shelf registration and insider sales. I think you’ll find, as I did, that neither of these concerns are very serious: Insider SalesComplete Story » seekingalpha.com |